NovoCure Ltd — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Leupin Nicolas | Chief Medical Officer | Sale | 830 | $19.92 | $16,534 | 50,294 | Feb 27, 2025 |
| Leupin Nicolas | Chief Medical Officer | Sale | 161 | $20.55 | $3,309 | 50,133 | Feb 27, 2025 |
| Puri Michal Nath | Chief Human Resources Officer | Sale | 1,162 | $19.92 | $23,147 | 108,931 | Feb 27, 2025 |
| Paravasthu Mukund | Chief Operating Officer | Sale | 2,160 | $26.81 | $57,910 | 31,437 | Jan 11, 2025 |
| Danziger Asaf | — | Award / Grant | 412 | $14.75 | $6,077 | 15,640 | Jan 1, 2025 |
| Ben Arye Barak | General Counsel | Award / Grant | 669 | $14.75 | $9,868 | 118,721 | Dec 31, 2024 |
| Cordova Ashley | Chief Executive Officer | Award / Grant | 373 | $14.75 | $5,502 | 219,552 | Dec 31, 2024 |
| Paravasthu Mukund | Chief Operating Officer | Sale | 44 | $16.69 | $734 | 3,459 | Nov 4, 2024 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Sale | 598 | $15.94 | $9,532 | 161,236 | Nov 1, 2024 |
| Paravasthu Mukund | Chief Operating Officer | Sale | 160 | $15.88 | $2,541 | 3,503 | Nov 1, 2024 |
| Puri Michal Nath | Chief Human Resources Officer | Sale | 810 | $15.79 | $12,790 | 110,093 | Oct 31, 2024 |
| Cordova Ashley | Chief Financial Officer | Sale | 688 | $20.14 | $13,856 | 219,179 | Aug 2, 2024 |
| Ben Arye Barak | General Counsel | Award / Grant | 930 | $12.24 | $11,383 | 118,052 | Jun 28, 2024 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Award / Grant | 1,055 | $12.24 | $12,913 | 252,290 | Jun 28, 2024 |
| Danziger Asaf | Chief Executive Officer | Award / Grant | 1,239 | $12.24 | $15,165 | 15,228 | Jun 28, 2024 |
| Cordova Ashley | Chief Financial Officer | Award / Grant | 1,286 | $12.24 | $15,741 | 220,465 | Jun 28, 2024 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Award / Grant | 1,736 | $12.24 | $21,249 | 161,834 | Jun 28, 2024 |
| Puri Michal Nath | Chief Human Resources Officer | Award / Grant | 1,736 | $12.24 | $21,249 | 110,903 | Jun 28, 2024 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Option Exercise | 124,373 | $22.82 | $2,838,192 | 124,373 | Jun 5, 2024 |
| Ocean Allyson J | — | Award / Grant | 4,053 | — | — | 4,053 | Jun 5, 2024 |
| Madden Martin J. | — | Award / Grant | 4,053 | — | — | 19,673 | Jun 5, 2024 |
| Hung David | — | Award / Grant | 4,053 | — | — | 13,194 | Jun 5, 2024 |
| Stafford Kristin | — | Award / Grant | 4,053 | — | — | 4,053 | Jun 5, 2024 |
| Scannell Timothy J | — | Sale | 964 | $23.89 | $23,030 | 2,964 | Jun 5, 2024 |
| LEUNG GABRIEL | — | Sale | 964 | $23.89 | $23,030 | 78,175 | Jun 5, 2024 |
| HILLEMAN JERYL L | — | Award / Grant | 4,053 | — | — | 6,590 | Jun 5, 2024 |
| VERNON W ANTHONY | — | Award / Grant | 4,053 | — | — | 169,850 | Jun 4, 2024 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Sale | 1,217 | $16.01 | $19,484 | 251,235 | Mar 1, 2024 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Sale | 840 | $16.01 | $13,448 | 160,098 | Mar 1, 2024 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Award / Grant | 3 | $12.69 | $38 | 209,828 | Feb 28, 2024 |
| Cordova Ashley | Chief Financial Officer | Award / Grant | 102,249 | $16.30 | $1,666,659 | 219,867 | Feb 27, 2024 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Sale | 2,078 | $16.14 | $33,539 | 162,617 | Feb 27, 2024 |
| Puri Michal Nath | Chief Human Resources Officer | Award / Grant | 71,574 | $16.30 | $1,166,656 | 109,167 | Feb 27, 2024 |
| Weinberg Uri | Chief Innovation Officer | Award / Grant | 81,799 | $16.30 | $1,333,324 | 171,148 | Feb 27, 2024 |
| Leupin Nicolas | Chief Medical Officer | Award / Grant | 51,124 | $16.30 | $833,321 | 51,124 | Feb 27, 2024 |
| Giladi Moshe | Chief Science Officer | Award / Grant | 51,124 | $16.30 | $833,321 | 69,771 | Feb 27, 2024 |
| Ben Arye Barak | General Counsel | Award / Grant | 128 | $12.69 | $1,624 | 35,323 | Feb 27, 2024 |
| Shah Pritesh | Chief Growth Officer | Sale | 382 | $12.65 | $4,832 | 124,511 | Nov 7, 2023 |
| Puri Michal Nath | Chief Human Resources Officer | Award / Grant | 37,593 | — | — | 37,593 | Oct 31, 2023 |
| Cordova Ashley | Chief Financial Officer | Option Exercise | 2,480 | $11.44 | $28,371 | 109,691 | Oct 31, 2023 |
| Cordova Ashley | Chief Financial Officer | Sale | 883 | $21.82 | $19,267 | 99,650 | Sep 1, 2023 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Sale | 294 | $21.82 | $6,415 | 209,825 | Sep 1, 2023 |
| Shah Pritesh | Chief Growth Officer | Sale | 273 | $21.82 | $5,957 | 124,893 | Sep 1, 2023 |
| Cordova Ashley | Chief Financial Officer | Sale | 1,144 | $30.25 | $34,606 | 100,533 | Aug 2, 2023 |
| Weinberg Uri | Chief Innovation Officer | Award / Grant | 305 | $35.28 | $10,760 | 89,349 | Jun 30, 2023 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | Award / Grant | 366 | $35.28 | $12,912 | 210,119 | Jun 30, 2023 |
| Shah Pritesh | Chief Growth Officer | Award / Grant | 367 | $35.28 | $12,948 | 125,166 | Jun 30, 2023 |
| Burke William Patrick | Chief Human Resources Officer | Award / Grant | 357 | $35.28 | $12,595 | 66,447 | Jun 30, 2023 |
| Ben Arye Barak | General Counsel | Award / Grant | 288 | $35.28 | $10,161 | 35,195 | Jun 30, 2023 |
| Cordova Ashley | Chief Financial Officer | Award / Grant | 367 | $35.28 | $12,948 | 101,677 | Jun 30, 2023 |